Pars Zist Electromagnetics Co

The work of Pars Zist Electromagnetis (Pars Tarava) began with a strong interest in the practical application of academic theses. We offer innovative products that bring greater speed and precision to today’s research. Through extensive studies and research, we now provide optimized systems for a wide range of applications in the fields of life sciences and medical technology.

Since 2018, Pars Zist Electromagnetis has operated as the first and only manufacturer of electroporation and electrochemotherapy devices and related accessories. The company initiated its foundational research in 2006, and its team members have participated in numerous studies in the fields of electroporation and electrochemotherapy. The company’s exclusive focus on these two technologies enables it to offer deep expertise and experience, delivering a broad range of innovative tools to advance research and cancer treatment.

Aligned with other manufacturers of advanced non-ionizing systems, the company provides state-of-the-art methods to hospital and academic users. The therapeutic achievements of the company’s collaborators have made it possible to treat superficial and deep solid tumors, as well as brain cancers.

Within the research portfolio, the Electroporation Device 3000 (approved as a knowledge-based product), along with 2 mm electroporation cuvettes and 4 mm electroporation cuvettes, are offered as some of the most advanced electroporation systems in the company’s product lineup. The expertise of our colleagues across technical, biotechnology, and clinical domains makes it easier to respond effectively to your needs.